clinical trials

AstraZeneca halts asthma study in blow to Synairgen
BioPharma Dive
Wed, 10/12/16 - 11:19 pm
AstraZeneca
asthma
Synairgen
clinical trials
AZD9412
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Yahoo/Benzinga
Sat, 10/8/16 - 03:46 pm
Kite Pharma
clinical trials
KTE-C19
CAR-T
refractory lymphoma
Alnylam Pharma stock plummets 45% after discontinuing drug on patient safety concerns
Marketwatch
Thu, 10/6/16 - 09:24 am
Alnylam
clinical trials
revusiran
Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug
Xtalks
Wed, 10/5/16 - 05:25 pm
Cempra
clinical trials
NASH
liver disease
Solithromycin
Alnylam shares crater after deaths force investigators to scrap PhIII RNAi drug
Endpoints
Wed, 10/5/16 - 05:19 pm
Alnylam
RNAi
clinical trials
AstraZeneca's Brilinta Didn't Meet Primary Endpoint
Yahoo/Benzinga
Tue, 10/4/16 - 10:12 pm
AstraZeneca
Brilinta
PAD
peripheral artery disease
clinical trials
Comorbidity Could Be Key To Alzheimer’s Clinical Trial Failures
Xtalks
Tue, 10/4/16 - 10:27 am
Alzheimer's disease
comorbidity
clinical trials
Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista
Yahoo/Benzinga
Tue, 10/4/16 - 10:17 am
Regeneron
Eylea
clinical trials
Ophthotech
Fovista
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Regeneron's Eylea combination therapy fails mid-stage study
Yahoo/Reuters
Fri, 09/30/16 - 09:45 am
Regeneron
Eylea
clinical trials
wet age-related macular degeneration
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Amgen
Kyprolis
clinical trials
Multiple Myeloma
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Diabetes drugs are badly needed, but rarely make it to market
Stat/Pharmalot
Tue, 09/27/16 - 09:46 am
diabetes
R&D
clinical trials
Evaluating FDA’s Approach to Cancer Clinical Trials
FDA Voice
Thu, 09/22/16 - 09:21 am
FDA
clinical trials
Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet
Cafepharma/Globe Newswire
Thu, 09/22/16 - 09:11 am
Interleukin Genetics
antisense
clinical trials
IONIS-APO(a)-LRX
Ionis’s Orphan Drug in Third Phase of Clinical Trials
Market Realist
Thu, 09/22/16 - 09:07 am
Ionis Pharmaceuticals
clinical trials
orphan drugs
Volanesorsen
Gilead scraps a PhII/III study early as drug flops against ulcerative colitis
Endpoints
Wed, 09/21/16 - 10:53 pm
Gilead Sciences
ulcerative colitis
clinical trials
GS-5745
Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yahoo
Mon, 09/19/16 - 09:51 am
Seattle Genetics
clinical trials
SGN-CD123A
AML
acute myeloid leukemia
Novavax shares plummet more than 80% after vaccine trial fails
Marketwatch
Fri, 09/16/16 - 09:33 am
Novavax
vaccines
clinical trials
RSV
Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
Marketwatch
Thu, 09/15/16 - 09:50 am
Merck
Pfizer
diabetes
clinical trials
ertugliflozin

Pages